AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Geratherm Medical AG

Earnings Release Mar 23, 2004

178_rns_2004-03-23_391f2f7a-0851-4243-b706-b67487e97804.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 23 March 2004 08:19

Geratherm with good results for 2003

Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– DGAP-Ad hoc: Geratherm Medical AG Geratherm with good results for 2003 The 2003 business year has been successful for Geratherm Medical. The turnover in 2003 rose by 11.3 % to EUR 7.5 million. The Group earnings after tax (EAT) increased by 63.4 % to EUR 1.56 million. The earnings per share also increased by 66.7% from EUR 0.21 to EUR 0.35. The earnings before interest and tax (EBIT) in the amount of EUR 768 thousand remained at the good level of the previous year, due to the exchange rate. The positive financial result in the amount of EUR 614 thousand (previous year EUR 28 k) increased the result of ordinary business activity in the year 2003 to EUR 1.4 million, which corresponds with an increase of 72% as compared to the previous year. The proposal for dividend payment for the 2003 business year by the Management Board and the Supervisory Board amounts to EUR 0.24 (previous year EUR 0.20) per share. The dividend payment is made from the tax deposit account (formerly EK04) and is thus tax free. In one of the main development projects of Geratherm, the Cardio-Monitor for the early detection of atrial fibrillation/stroke, the phase III clinical trial could be successfully completed on 3 March 2004. The detailed balance numbers (IFRS) for the 2003 business year shall be published on 14 April 2004. As regards the prospects for the current business year of 2004, the company assumes there will be a positive course in turnover and earnings. Geratherm Medical AG, listed on the Prime Standard, develops, produces and sells systems for the measurement and transmission of vital parameters. Geratherm Medical AG, Fahrenheitstraße 1, D-98716 Geschwenda Editing contact: Martina Schramm, phone: ++49(0)36205/98 111, fax: ++49(0)36205/98 115 E-mail: [email protected] – end of message end of ad-hoc-announcement (c)DGAP 23.03.2004 ——————————————————————————– WKN: 549562; ISIN: DE0005495626; Index: Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, München und Stuttgart 230819 Mär 04

Talk to a Data Expert

Have a question? We'll get back to you promptly.